Linezolid penetration into osteo-articular tissues

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue 5, 2002, Pages 747-750

  Rana, B ^a   Butcher, I ^a   Grigoris, P ^a   Murnaghan, C ^a   Seaton, R A ^a   Tobin, C M ^b  

^a WESTERN INFIRMARY   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Bone and joint infection; Linezolid; Osteo articular tissue; Osteomyelitis; Oxazolidinone; Pharmacokinetics

Indexed keywords

CEFUROXIME; LINEZOLID; ACETAMIDE DERIVATIVE; OXAZOLIDINONE DERIVATIVE;

AGED; ANESTHESIA INDUCTION; ARTICLE; ARTICULAR CARTILAGE; BONE INFECTION; BONE TISSUE; CANCELLOUS BONE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BONE LEVEL; DRUG DETERMINATION; DRUG MUSCLE LEVEL; DRUG PENETRATION; DRUG SYNOVIAL FLUID LEVEL; DRUG TISSUE LEVEL; DRUG USE; FEMALE; GRAM POSITIVE BACTERIUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFECTIOUS ARTHRITIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PREOPERATIVE TREATMENT; SOFT TISSUE INFECTION; STAPHYLOCOCCUS; STREPTOCOCCUS; SYNOVIAL FLUID; TOTAL KNEE REPLACEMENT; BLOOD; BONE; DRUG EFFECT; KNEE OSTEOARTHRITIS; METABOLISM; MUSCLE; RHEUMATOID ARTHRITIS; TISSUE DISTRIBUTION;

ACETAMIDES; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BONE AND BONES; FEMALE; HUMANS; MALE; MUSCLES; OSTEOARTHRITIS, KNEE; OXAZOLIDINONES; SYNOVIAL FLUID; TISSUE DISTRIBUTION;

EID: 0036850671     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf207     Document Type: Article

References (10)

1. Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M. et al. (1997). Mechanisms of actions of oxazlidinones: effects of linezolid and eperezolid on translation reactions. Antimicrobial Agents and Chemotherapy 41, 2132-6.
2. Rybak, M. J., Hershberger, E., Moldovan, T. & Grucz, R. G. (2000). In vitro activities of daptomycin, vancomycin, linezolid and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrobial Agents and Chemotherapy 44, 1062-6.
3. Moise, P. A., Birmingham, M. C., Forrest, A. & Schentag, J. J. (2000). Linezolid use in patients who are intolerant to or fail vancomycin. In Proceedings of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 16 September 2000. Abstract 2233, p. 487. American Society for Microbiology, Washington, DC, USA.
4. Andrews, J. M. (1999). The assay of antimicrobials in tissues and fluids. In Clinical Antimicrobial Assays (Reeves, D. S., Wise, R., Andrews, J. M. & White, L. O., Eds), pp. 65-75. Oxford University Press, Oxford, UK.
5. Tobin, C. M., Sunderland, J., White, L. O. & MacGowan, A. (2001). A simple, isocratic high performance liquid chromatography (HPLC) assay for linezolid in human serum. Journal of Antimicrobial Chemotherapy 48, 605-8.
6. Lovering, A. M., Zhang, G., Bannister, G. C., Lankester, B. J. A., Brown, J. H. M., Narendra, G. et al. (2002). Linezolid penetration into bone, fat, muscle and haematoma of patients undergoing routine hip replacement. Journal of Antimicrobial Chemotherapy 50, 73-7.
7. Johnson, A. P., Warner, M. & Livermore, D. M. (2000). Activity of linezolid against multi-resistant Gram-positive bacteria from diverse hospitals in the United Kingdom. Journal of Antimicrobial Chemotherapy 45, 225-30.
8. Li, Z., Willke, R. J., Pinto, L. A., Rittenhouse, B. E., Rybak, M. J., Pleil, A. M. et al. (2001). Comparison of length hospital stay for patients with known or suspected methicillin resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomised, multicenter trial. Pharmacotherapy 21, 263-74.
9. Bassetti, M., Cenderello, G., Di Biagio, A., Del Bono, V., Rosso, R., Gatti, G. et al. (2000). Linezolid treatment for prosthetic hip infections due to methicillin-resistant Staphylococcus aureus (MRSA). In Proceedings of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 16 September 2000. Abstract 2231, p. 487. American Society for Microbiology, Washington, DC, USA.
10. Green, S., Maddox, J. C. & Huttenbach, E. D. (2001). Linezolid and reversible myelosuppression. Journal of the American Medical Association 285, 1291.